跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PCI-34051
首页
药物
PCI-34051
PCI-34051
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of HDAC8 inhibitor in preparation of medicine for treating fibrous dysplasia
CN 110420208 A
申请人: AFFILIATED STOMATOLOGICAL HOSPITAL NANJING MED UNIV
优先权: 2019
CN
HDCA8 specific inhibitor induced exosome and application thereof
CN 113980886 A
申请人: FIRST HOSPITAL CHINA MEDICAL UNIV
优先权: 2021
CN
Targeted histone deacetylase 8 proteolysis chimera, preparation method and application thereof
CN 117736201 A
申请人: UNIV SHENZHEN
优先权: 2022
CN
Application of PCI-34051 in preparation of medicine for treating or preventing aortic dissection
CN 120189409 A
申请人: AFFILIATED TONGJI HOSPITAL OF TONGJI MEDICAL COLLEGE OF HUAZHONG UNIV SCI & TECH
优先权: 2025
CN
药物
反馈